Track CDXS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Codexis Inc
200 Penobscot Drive, Redwood City, CA, United States, 94063
IPO
2010
Employees
146
Industry
Biotechnology
Sector
Healthcare
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 20265-5
0
Q4 20252-2
0
2-quarter cumulative
7 sells0 buys
Analyst Ratings
3 analysts covering
Hold67%recommend hold
Buy
1
Hold
2
Sell
0